1. Vaidyanathan S, Rao MS, Sharma PL, Chary KS, Swamy RP . Possible use of indoramin in patients with chronic neurogenic bladder dysfunction. J Urol 1983; 129: 96–101.
2. Department of Health & Human Services, Public Health Service, Food and Drug Administration, USA. 15 January 2003.
http://www.fda.gov/cder/foi/appletter/2003/08708slr022ltr.pdf
.
3. The Registry of Toxic Effects of Chemical Substances, National Institute of Occupational Health and Safety, USA. June 2000.
http://www.cdc.gov/niosh/rtecs/dp393870.html
.
4. Nettesheim O, Hoffken G, Gahr M, Breidert M . Haematemesis and dysphagia in a 20-year-old woman with congenital spine malformation and situs inversus partialis. Z Gastroenterol 2003; 41: 319–324.
5. British National Formulary. Vol 49, British Medical Association and Royal Pharmaceutical Society of Great Britain, London, March 2005, p 96.